Biofrontera Inc
Research Biofrontera Inc (BFRI) on Bullrun: market cap USD 13.78M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBFRI
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 13.78M
- Financial periodQ2 2026
- RevenueUSD 12.00M
- Net income-USD 604.00K
- Free cash flow-USD 1.66M
- Gross margin79.9%
Valuation Snapshot
latest market cap is USD 13.78M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 41.71M | -USD 10.54M | -USD 13.36M | 73.7% | -1.04 | USD 6.39M | USD 6.16M | USD 10.48M |
| FY2024 | USD 37.32M | -USD 17.76M | -USD 10.28M | 50.1% | -3.22 | USD 5.91M | USD 4.92M | USD 4.43M |
| FY2023 | USD 34.07M | -USD 20.13M | -USD 24.90M | 48.8% | -13.02 | USD 1.34M | USD 3.90M | USD 4.79M |
| FY2022 | USD 28.67M | -USD 640.00K | -USD 16.24M | 47.0% | -0.61 | USD 17.21M | USD 1.35M | USD 23.88M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 13.78M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 6.64M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 9.67M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 4.20M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 24.48M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 128.62M | n/a | n/a | n/a |
About Biofrontera Inc
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Biofrontera Inc's market cap?
Biofrontera Inc's market capitalization is USD 13.78M.
What does Biofrontera Inc do?
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.